Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2016

NephroGenex, Inc. (NRX) Starts Presentation at NobleCon12 Investor Conference

Posted on January 18, 2016 by MissionIR

NephroGenex, Inc. (NASDAQ: NRX) is an innovator in the development of drugs to treat kidney disease, with a first indication in diabetic nephropathy. NephroGenex has been pioneering the development of PYRIDORIN (pyridoxamine dihydrochloride), a late stage compound to treat diabetic … Continue reading →

Posted in Noble Equity Conference | Leave a comment

VBI Vaccines, Inc. (VBIV) Starts Presentation at NobleCon12 Investor Conference

Posted on January 18, 2016 by MissionIR

VBI Vaccines, Inc. (NASDAQ: VBIV) is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s eVLP vaccine platform allows for the design of enveloped (“e”) virus-like particle (“VLP”) vaccines that closely mimic … Continue reading →

Posted in Noble Equity Conference | Leave a comment

OmniComm Systems, Inc. (OMCM) Starts Presentation at NobleCon12 Investor Conference

Posted on January 18, 2016 by MissionIR

OmniComm Systems, Inc. (OTC: OMCM) is a leading strategic software solutions provider to the life sciences industry. OmniComm Systems is dedicated to helping the world’s pharmaceutical; biotechnology; contract research organizations; diagnostic and device firms; and academic medical centers maximize the … Continue reading →

Posted in Noble Equity Conference | Leave a comment

Palatin Technologies, Inc. (PTN) Starts Presentation at NobleCon12 Investor Conference

Posted on January 18, 2016 by MissionIR

Palatin Technologies, Inc. (NYSE: PTN) is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin’s programs are based on molecules that modulate the activity of the melanocortin … Continue reading →

Posted in Noble Equity Conference | Leave a comment

Oakridge Global Energy Solutions, Inc. (OGES) Adheres to a Strict Quality Policy from which Everyone Can Benefit

Posted on January 15, 2016 by MissionIR

An energy reserve company, Oakridge Global Energy Solutions (OTCQB: OGES) uses innovative technology to develop cells, batteries, and energy storage systems. The company produces large and small prismatic lithium cells using proprietary technology. These cells are easily stackable, which allows … Continue reading →

Posted in Oakridge Global Energy Solutions Inc. OGES | Leave a comment

Moxian, Inc. (MOXC) is a Pioneer in the Billion Dollar O2O Market

Posted on January 14, 2016 by MissionIR

Ecommerce is on the rise. In the U.S., according to Statista, the online statistics portal, retail ecommerce sales climbed over 30% in the last two years, from about $261 billion in 2013 to an estimated $341 billion in 2015. That … Continue reading →

Posted in Moxian Inc. MOXC | Leave a comment

OurPet’s Company (OPCO) Wields Success in a Booming Market

Posted on January 14, 2016 by MissionIR

Founded in 1995, OurPet’s Company (OTCQX: OPCO) develops and markets innovative products that aim to improve the health, safety, and enjoyment of household pets like dogs, cats, and birds. Pet owners can be confident that the company’s 800 mostly patented … Continue reading →

Posted in OurPet’s Company OPCO | Leave a comment

Sernova Corp. (SEOVF) Starts Presentation at Biotech Showcase Conference

Posted on January 13, 2016 by MissionIR

Sernova Corp. (OTC: SEOVF) is a clinical stage regenerative medicine company focused on developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including hemophilia and other diseases treated through replacement of proteins or … Continue reading →

Posted in Biotech Showcase Conference | Leave a comment

Provectus Biopharmaceuticals, Inc. (PVCT) Starts Presentation at Biotech Showcase Conference

Posted on January 13, 2016 by MissionIR

Provectus Biopharmaceuticals, Inc. (NYSE: PVCT) specializes in developing oncology and dermatology therapies. PV-10, the company’s novel investigational drug for cancer, is designed for injection into solid tumors, thereby reducing potential for systemic side effects. Its oncology focus is on melanoma, … Continue reading →

Posted in Biotech Showcase Conference | Leave a comment

Pressure BioSciences, Inc. (PBIO) Starts Presentation at Biotech Showcase Conference

Posted on January 13, 2016 by MissionIR

Pressure BioSciences, Inc. (OTC: PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. The company’s products are based on the unique properties of both constant and alternating (pressure cycling technology, or … Continue reading →

Posted in Biotech Showcase Conference | Leave a comment